A Long Term Safety Study of Mavrilimumab in Adult Subjects With Rheumatoid Arthritis

NCT01712399 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
409
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated after approximately 3 years due to future clinical development plans, including ethical considerations.

Conditions

Interventions

Sponsor

MedImmune LLC